As global markets experience a mix of trends with the STOXX Europe 600 Index and France’s CAC 40 showing positive movements, investors are keenly observing shifts in economic indicators and their implications on investment opportunities. In such an environment, growth companies with high insider ownership in France present a unique appeal, potentially aligning closely-held conviction with robust earnings growth amidst evolving market dynamics.

Top 10 Growth Companies With High Insider Ownership In France

Name Insider Ownership Earnings Growth VusionGroup (ENXTPA:VU) 13.5% 25.2% Groupe OKwind Société anonyme (ENXTPA:ALOKW) 24.8% 30.8% Adocia (ENXTPA:ADOC) 11.9% 63% Icape Holding (ENXTPA:ALICA) 30.2% 26.2% La Française de l'Energie (ENXTPA:FDE) 20.1% 31.9% Arcure (ENXTPA:ALCUR) 21.4% 27.5% S.M.A.I.O (ENXTPA:ALSMA) 17.3% 35.2% Munic (ENXTPA:ALMUN) 29.4% 149.2% MedinCell (ENXTPA:MEDCL) 16.4% 69.6% OSE Immunotherapeutics (ENXTPA:OSE) 25.6% 5.9%

Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's dive into some prime choices out of from the screener.

Lectra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions across the fashion, automotive, and furniture sectors in various global regions including Northern Europe, Southern Europe, the Americas, and Asia Pacific, with a market capitalization of approximately €1.08 billion.

Operations: The company generates revenue from the Americas and Asia-Pacific regions, totaling approximately €170.33 million and €110.28 million respectively.

Insider Ownership: 19.6%

Earnings Growth Forecast: 28.6% p.a.

Lectra, a French company with significant insider ownership, is trading at 35.2% below its estimated fair value, presenting a potentially undervalued opportunity. Analyst consensus suggests the stock price could rise by 21.9%. Despite lower-than-benchmark forecasted Return on Equity at 13.3%, Lectra's earnings are expected to grow significantly at 28.6% per year, outpacing the French market's growth of 10.9%. Recent financials indicate stable performance with slight variations in net income and EPS from the previous year.

Navigate through the intricacies of Lectra with our comprehensive analyst estimates report here. Our comprehensive valuation report raises the possibility that Lectra is priced lower than what may be justified by its financials. ENXTPA:LSS Earnings and Revenue Growth as at Jul 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company that specializes in developing long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €431.26 million.



Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €11.95 million.

Insider Ownership: 16.4%

Earnings Growth Forecast: 69.6% p.a.

MedinCell, a French growth company with high insider ownership, has demonstrated a challenging yet potentially promising trajectory. Despite recent financial setbacks with a reported net loss of €25.04 million and declining revenues to €11.95 million in 2024, MedinCell is actively engaging in significant industry conferences and advancing its pharmaceutical innovations. Notably, its collaboration with AbbVie could infuse up to €1.9 billion into development milestones plus royalties on sales, underscoring substantial future revenue streams from its long-acting injectable technology platform. However, volatility in share price and recent trial failures suggest caution among investors seeking stable growth avenues.

Click here to discover the nuances of MedinCell with our detailed analytical future growth report. According our valuation report, there's an indication that MedinCell's share price might be on the expensive side. ENXTPA:MEDCL Ownership Breakdown as at Jul 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. offers a range of cloud services and hosting solutions globally, with a market capitalization of approximately €1.07 billion.

Operations: The company generates revenue through three primary segments: public cloud (€169.01 million), private cloud (€589.61 million), and web cloud (€185.43 million).

Insider Ownership: 10.5%

Earnings Growth Forecast: 103.7% p.a.

OVH Groupe, a French growth company with significant insider ownership, is navigating a path to profitability with expectations to turn profitable within the next three years. Currently trading at 25.4% below its estimated fair value, OVH's earnings are projected to increase substantially. Despite this promising outlook, its revenue growth of 10.8% per year trails behind the desired 20% threshold for high-growth entities but still surpasses the French market average of 5.7%. Recent innovations in server technology could bolster future performance, although its return on equity is anticipated to remain low at 1.7%.

Take a closer look at OVH Groupe's potential here in our earnings growth report. Our valuation report here indicates OVH Groupe may be undervalued. ENXTPA:OVH Ownership Breakdown as at Jul 2024

Taking Advantage

Unlock our comprehensive list of 21 Fast Growing Euronext Paris Companies With High Insider Ownership by clicking here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Interested In Other Possibilities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTPA:LSSENXTPA:MEDCL and ENXTPA:OVH.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]